CGN Share Price Performance
Recent CGN News & Updates
No updates
Cognetivity Neurosciences Ltd. Key Details
Last Reported Earnings
Oct 31, 2023
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.092
- Gross Margin
- -1,278.71%
- Net Profit Margin
- -8,732.77%
- Debt/Equity Ratio
- -19.9%
Cognetivity Neurosciences Ltd. Competitors
About CGN
- Founded
- 2015
- Employees
- n/a
- CEO
- WebsiteView website
Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Canadian Market Performance
- 7 Days: 0.4%
- 3 Months: 10.1%
- 1 Year: 17.4%
- Year to Date: 10.2%
The market has stayed flat over the 7 days. Meanwhile, the market is actually up 17% over the past year. Earnings are forecast to grow by 12% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading